NCT06153758View on ClinicalTrials.gov

Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 27, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Healthy ParticipantsHealthy Subjects
Interventions
DRUG

Danuglipron

Danuglipron oral tablets

Trial Locations (1)

92801

Anaheim Clinical Trials, LLC, Anaheim

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06153758 - Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults | Biotech Hunter | Biotech Hunter